Skandinaviska Enskilda Banken (SEB)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.7M | Sell |
84,888
-1,236
| -1% | -$403K | 0.12% | 143 |
|
|
2025
Q1 | $23.3M | Sell |
86,124
-39,367
| -31% | -$10.6M | 0.11% | 154 |
|
|
2024
Q4 | $29.6M | Sell |
125,491
-24,628
| -16% | -$5.81M | 0.13% | 135 |
|
|
2024
Q3 | $41.3M | Buy |
150,119
+43,227
| +40% | +$11.9M | 0.19% | 95 |
|
|
2024
Q2 | $26M | Buy |
106,892
+12,339
| +13% | +$3M | 0.12% | 141 |
|
|
2024
Q1 | $14.1M | Buy |
94,553
+1,296
| +1% | +$194K | 0.07% | 221 |
|
|
2023
Q4 | $17.9M | Buy |
93,257
+32
| +0% | +$6.13K | 0.1% | 188 |
|
|
2023
Q3 | $16.5M | Buy |
93,225
+404
| +0.4% | +$71.5K | 0.11% | 175 |
|
|
2023
Q2 | $17.6M | Sell |
92,821
-33,699
| -27% | -$6.4M | 0.12% | 182 |
|
|
2023
Q1 | $25.3M | Buy |
126,520
+34,954
| +38% | +$7M | 0.18% | 126 |
|
|
2022
Q4 | $21.8M | Sell |
91,566
-24,873
| -21% | -$5.91M | 0.16% | 148 |
|
|
2022
Q3 | $23.3M | Buy |
116,439
+25,905
| +29% | +$5.19M | 0.18% | 118 |
|
|
2022
Q2 | $13.2M | Buy |
90,534
+53,661
| +146% | +$7.83M | 0.1% | 201 |
|
|
2022
Q1 | $6.02M | Sell |
36,873
-9,616
| -21% | -$1.57M | 0.04% | 359 |
|
|
2021
Q4 | $7.95M | Buy |
46,489
+5,200
| +13% | +$889K | 0.04% | 337 |
|
|
2021
Q3 | $7.8M | Sell |
41,289
-8,375
| -17% | -$1.58M | 0.04% | 337 |
|
|
2021
Q2 | $8.42M | Buy |
49,664
+21,603
| +77% | +$3.66M | 0.05% | 319 |
|
|
2021
Q1 | $3.96M | Buy |
28,061
+1,639
| +6% | +$231K | 0.03% | 448 |
|
|
2020
Q4 | $3.43M | Sell |
26,422
-721
| -3% | -$93.7K | 0.02% | 472 |
|
|
2020
Q3 | $3.95M | Buy |
27,143
+4,589
| +20% | +$668K | 0.03% | 383 |
|
|
2020
Q2 | $3.34M | Buy |
22,554
+6,374
| +39% | +$944K | 0.03% | 427 |
|
|
2020
Q1 | $1.76M | Sell |
16,180
-5,150
| -24% | -$561K | 0.02% | 502 |
|
|
2019
Q4 | $2.46M | Buy |
21,330
+4,879
| +30% | +$562K | 0.02% | 503 |
|
|
2019
Q3 | $1.32M | Buy |
16,451
+3,330
| +25% | +$268K | 0.01% | 633 |
|
|
2019
Q2 | $952K | Sell |
13,121
-327
| -2% | -$23.7K | 0.01% | 658 |
|
|
2019
Q1 | $1.26M | Buy |
13,448
+188
| +1% | +$17.6K | 0.01% | 559 |
|
|
2018
Q4 | $967K | Buy |
13,260
+1,190
| +10% | +$86.8K | 0.01% | 652 |
|
|
2018
Q3 | $1.06M | Buy |
12,070
+800
| +7% | +$70K | 0.01% | 667 |
|
|
2018
Q2 | $1.11M | Buy |
11,270
+700
| +7% | +$68.9K | 0.01% | 602 |
|
|
2018
Q1 | $1.26M | Sell |
10,570
-5,730
| -35% | -$683K | 0.01% | 532 |
|
|
2017
Q4 | $2.07M | Buy |
+16,300
| New | +$2.07M | 0.02% | 439 |
|
|
2016
Q4 | – | Sell |
-10,100
| Closed | -$685K | – | 657 |
|
|
2016
Q3 | $685K | Buy |
+10,100
| New | +$685K | 0.01% | 616 |
|
|
2016
Q2 | – | Sell |
-9,200
| Closed | -$577K | – | 717 |
|
|
2016
Q1 | $577K | Hold |
9,200
| – | – | 0.01% | 624 |
|
|
2015
Q4 | $869K | Buy |
+9,200
| New | +$869K | 0.01% | 530 |
|